Publications by authors named "Maria Niewolna"

Claim this Profile
H
Halofuginone inhibits TGF-β/BMP signaling and in combination with zoledronic acid enhances inhibition of breast cancer bone metastasis.
Patricia Juárez, Pierrick G J Fournier, Khalid S Mohammad, Ryan C McKenna, Holly W Davis, Maria Niewolna

Oncotarget· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Excess TGF-β mediates muscle weakness associated with bone metastases in mice.
David L Waning, Khalid S Mohammad, Steven Reiken, Wenjun Xie, Daniel C Andersson, Maria Niewolna

Nat Med· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TGFβ-Mediated induction of SphK1 as a potential determinant in human MDA-MB-231 breast cancer cell bone metastasis.
Keith R Stayrook, Justin K Mack, Donna Cerabona, Daniel F Edwards, Hai H Bui, Maria Niewolna

Bonekey Rep· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The TGF-β Signaling Regulator PMEPA1 Suppresses Prostate Cancer Metastases to Bone.
Pierrick G J Fournier, Patricia Juárez, Guanglong Jiang, Gregory A Clines, Maria Niewolna

Cancer Cell· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor-expressed adrenomedullin accelerates breast cancer bone metastasis.
Valerie A Siclari, Khalid S Mohammad, Douglas R Tompkins, Holly Davis, C Ryan McKenna, Maria Niewolna

Breast Cancer Res· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Halofuginone inhibits the establishment and progression of melanoma bone metastases.
Patricia Juárez, Khalid S Mohammad, Juan Juan Yin, Pierrick G J Fournier, Ryan C McKenna, Maria Niewolna

Cancer Res· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regulation of postnatal trabecular bone formation by the osteoblast endothelin A receptor.
Gregory A Clines, Khalid S Mohammad, Jessica M Grunda, Katrina L Clines, Maria Niewolna

J Bone Miner Res· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TGF-beta-RI kinase inhibitor SD-208 reduces the development and progression of melanoma bone metastases.
Khalid S Mohammad, Delphine Javelaud, Pierrick G J Fournier, Maria Niewolna, C Ryan McKenna

Cancer Res· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hypoxia and TGF-beta drive breast cancer bone metastases through parallel signaling pathways in tumor cells and the bone microenvironment.
Lauren K Dunn, Khalid S Mohammad, Pierrick G J Fournier, C Ryan McKenna, Holly W Davis, Maria Niewolna

PLoS One· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacologic inhibition of the TGF-beta type I receptor kinase has anabolic and anti-catabolic effects on bone.
Khalid S Mohammad, Carol G Chen, Guive Balooch, Elizabeth Stebbins, C Ryan McKenna, Maria Niewolna

PLoS One· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effect of the bisphosphonate ibandronate on breast cancer metastasis to visceral organs.
Toshimi Michigami, Toru Hiraga, Paul J Williams, Maria Niewolna, Riko Nishimura

Breast Cancer Res Treat· October 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis